13 New IPOs Scheduled for the Week of April 7

Francis Gaskins |

The full IPO calendar is available at IPOpremium. Scheduled IPOs are ranked by IPO size. Almost $5 billion in scheduled new offerings.

(1) Based in Detroit, MI, Ally Financial ($ALLY) scheduled a $2.5 billion IPO on the NYSE with a market capitalization of $12.8 billion at a price range midpoint of $26.50 for Thursday, April 10, 2014.

Founded in 1919, ALLY is a leading automotive financial services company with over 90 years of experience providing a broad array of financial products and services to automotive dealers and their customers.

(2) Based in Irving, TX, La Quinta Inns & Suites ($LQ) scheduled a $725 million IPO on the NYSE with a market capitalization of $2.4 billion at a price range midpoint of $19.50 for Wednesday, April 9, 2014.

LQ is a leading owner, operator and franchisor of select-service hotels primarily serving the midscale and upper-midscale segments under the La Quinta brand.

(3) Based in Oklahoma City, OK, Enable Midstream Partners, LP ($ENBL) scheduled a $500 million IPO on the NYSE with a market capitalization of $8.32 billion at a price range midpoint of $20 for Friday, April 11, 2014.

ENBL is a large-scale, growth-oriented limited partnership formed to own, operate and develop strategically located natural gas and crude oil infrastructure assets.

(4) Based in Teaneck, NJ, Phibro Animal Health ($PAHC) scheduled a $200 million IPO on the Nasdaq with a market capitalization of $662 million at a price range midpoint of $17 for Friday, April 11, 2014.

PAHC is a global diversified animal health and mineral nutrition company.

(5) Based in Athens, Greece, Stalwart Tankers (STST) scheduled a $150 million IPO on the NYSE with a market capitalization of $188 million at a price range midpoint of $12 for Thursday, April 10, 2014.

STST is Stalwart Tankers Inc., a company recently organized under the laws of the Republic of the Marshall Islands to own and operate a fleet of mid-size stainless steel chemical tankers.

(6) Based in Beijing, China, iKang Healthcare Group ($KANG) scheduled a $142 million IPO on the Nasdaq with a market capitalization of $839 million at a price range midpoint of $13 for Wednesday, April 9, 2014.



KANG is the largest provider in China’s fast growing private preventive healthcare services market, accounting for approximately 12.3% of market share in terms of revenue in 2013, according to Frost & Sullivan.

(7) Based in Oklahoma City, OK, Paycom Software ($PAYC) scheduled a $126 million IPO on the NYSE with a market capitalization of $956 million at a price range midpoint of $19 for Friday, April 11, 2014.

PAYC is a leading provider of a comprehensive, cloud-based human capital management (HCM)  software solution delivered as SaaS.

(8) Based in Vancouver, Canada, City Office REIT ($CIO) scheduled a $101 million IPO on the NYSE with a market capitalization of $189 million at a price range midpoint of $15 for Friday, April 11, 2014.

CIO is a newly organized Maryland corporation formed on November 26, 2013 to acquire, own and operate high-quality office properties located within its specified markets in the United States.

(9) Based in Westminster, CO, Farmland Partners ($FPI) scheduled a $70 million IPO on the NYSE with a market capitalization of $102 million at a price range midpoint of $15 for Thursday, April 10, 2014.

FPI seeks to acquire high-quality primary row crop farmland located in agricultural markets throughout North America.

(10) Based in Plano, TX, Zoe’s Kitchen  ($ZOES) scheduled a $70 million IPO on the NYSE with a market capitalization of $221 million at a price range midpoint of $12 for Friday, April 11, 2014.

ZOES is a specialty fast casual restaurant with Mediterranean-inspired dishes.  As of February 24, 2014 ZOES had 111 restaurants in15 states.

(11) Based in Cambridge, MA, Cerulean Pharma ($CERU) scheduled a $60 million IPO on the Nasdaq with a market capitalization of $172 million at a price range midpoint of $12 for Thursday, April 10, 2014.

CERU’s nanopharmaceutical product candidates consist of proprietary polymers that are covalently linked to anti-cancer therapeutics, or payloads.

(12) Based in Emeryville, CA, Adamas Pharmaceuticals  ($ADMS) scheduled a $51 million IPO on the Nasdaq with a market capitalization of $279 million at a price range midpoint of $17 for Thursday, April 10, 2014.

ADMS is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system, or CNS.

(13) Based in Burlington, MA, Aldeyra Therapeutics ($ALDX) scheduled a $25 million IPO on the Nasdaq with a market capitalization of $69 million at a price range midpoint of $11 for Friday, April 11, 2014.

ALDX is a biotechnology company focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
PAYC Paycom Software Inc. 69.41 -2.36 -3.29 613,165 Trade
ADMS Adamas Pharmaceuticals Inc. 16.88 -0.51 -2.93 238,978 Trade
ENBL Enable Midstream Partners LP representing limited 15.54 0.29 1.90 291,400 Trade
CIO City Office REIT Inc. 12.71 -0.03 -0.24 100,807 Trade
CERU Cerulean Pharma Inc. 0.41 -0.02 -3.85 332,497 Trade
ALLY Ally Financial Inc. 20.99 0.23 1.11 4,927,050 Trade
FPI Farmland Partners Inc. 9.01 -0.19 -2.07 317,532 Trade
PAHC Phibro Animal Health Corporation 37.25 -0.20 -0.53 82,557 Trade
LQ La Quinta Holdings Inc. 14.93 -0.06 -0.40 1,319,191 Trade
ALDX Aldeyra Therapeutics Inc. 4.45 0.00 0.00 35,392 Trade
ZOES Zoe\'s Kitchen Inc. 12.41 -0.27 -2.13 505,374 Trade
PTAIY P.T. Astra International TBK ADR 13.54 -0.13 -0.91 33,341

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…